Viereckl, M.J.; Krutsinger, K.; Apawu, A.; Gu, J.; Cardona, B.; Barratt, D.; Han, Y.
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules 2022, 12, 854.
https://doi.org/10.3390/biom12060854
AMA Style
Viereckl MJ, Krutsinger K, Apawu A, Gu J, Cardona B, Barratt D, Han Y.
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules. 2022; 12(6):854.
https://doi.org/10.3390/biom12060854
Chicago/Turabian Style
Viereckl, Michael J., Kelsey Krutsinger, Aaron Apawu, Jian Gu, Bryana Cardona, Donovan Barratt, and Yuyan Han.
2022. "Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways" Biomolecules 12, no. 6: 854.
https://doi.org/10.3390/biom12060854
APA Style
Viereckl, M. J., Krutsinger, K., Apawu, A., Gu, J., Cardona, B., Barratt, D., & Han, Y.
(2022). Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules, 12(6), 854.
https://doi.org/10.3390/biom12060854